At $31 a day, is Vertex’s new non-addictive painkiller worth the price?
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at least as effective and costs only 50 cents a pill? They will if the generic drug is an opioid that carries the potential for addiction and the new medicine is a non-opioid that poses no such known risk.
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug ...
I’m Conway Gittens reporting from the New York Stock Exchange. Here’s what we’re watching on TheStreet today. Wall Street ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
To help provide relief without the risk of abuse and overdoses, one pharmaceutical company is revealing its new pill designed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback